Roche Holding AG

World Rank (Jul-30-2023)
38
Market Cap (Jul-30-2023)
249.730 Billion USD
World Rank (Dec-25-2022)
32
Market Cap (Dec-25-2022)
261.410 Billion USD
World Rank (Jan-07-2022)
25
Market Cap (Jan-07-2022)
356.150 Billion USD
World Rank (Jan-01-2021)
25
Market Cap (Jan-01-2021)
295.780 Billion USD
Annual Revenue in USD
72,691 Million USD
Annual Net Income in USD
14,267 Million USD
Total Assets in USD
101,260 Million USD
Total Liabilities in USD
73,484 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters State / City
Basel
Headquarters Country
Switzerland
Company Business
Healthcare
Pharmaceutical
Medical Equipment
Biotechnology
Healthcare Service
Stock Category
S&P EUROPE 350
Stock Exchange
Switzerland
Company Rank in Country in 2022
Company Rank in Switzerland in 2022 is 2
Rank in Country (Jan-2021)
Company Rank in Switzerland in 2021 is 2
Number of Employees
103,613
Employee Count as on Date
As on 2022
Chairman
Christoph Franz
CEO:
Severin Schwan
Founders
Fritz Hoffmann-La Roche
Billionaires related to Enterprise:
Andre Hoffmann
Andreas Oeri
Maja Oeri
Catherine Oeri
Jorg Duschmale
Sabine Duschmale Oeri
Vera Michalski Hoffmann
Lukas Duschmale
Maja Hoffmann
Yahoo
Yahoo @ Switzerland
Wikipedia
Wikipedia
Company Website:
Roche - Healthcare and Pharmaceutical Company
About Company Business:

Roche Holding is a pioneer in Healthcare Company with headquarters in Basel, Switzerland. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology and Respiratory branches Medicines.

Facts About Company

Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

63 million patients treated with medicines of Roche Holding.

Founded Year
1896
Annual Results Summary:

Roche Holding AG - Annual Results - Revenue and Net Profit - in Billion CHF

Annual Results Revenue Operating Income Net Income
Dec-2022 63.28 17.47 12.42
Dec-2021 62.80 18.15 13.93
Dec-2020 58.32 18.54 14.29
Dec-2019 61.46 17.55 13.49
Dec-2018 56.84 14.74 10.50
Dec-2017 53.29 13.00  8.63
Dec-2016 50.57   9.57
Dec-2015 48.10   8.80
Balance Sheet Summary

Roche Holding AG - Balance Sheet Summary - in Billion CHF

Yearly - Ending Total Assets Total Liabilities Total Equity
Dec-2022 88.15 63.97 32.0
Dec-2021 92.31 67.8 24.4
Dec-2020 87.88 50.0 37.8
Dec-2019 86.14 49.7 36.3
Quarterly Results Summary:

Roche Holding AG - Half Yearly Results - Revenue and Net Profit - in Billion CHF

Half Year Ending Revenue Net Profit EPS (CHF)
Jun-2023 29.78 7.14 7.14
Dec-2022 30.99 3.89 3.89
Jun-2022 32.30 8.53 8.53
Dec-2021 32.08 6.12 7.14
Jun-2021 30.71 7.80 9.14
Dec-2020 29.04 6.22 7.27
Jun-2020 29.28 8.46 10.44
Dec-2019 31.00 4.88 5.70
Jun-2019 30.47 8.62 11.12
Dec-2018 28.74 3.19 3.73
Jun-2018 28.11 7.31 8.56
Dec-2017 26.96 3.16 3.70

Share it on Social Media